A clinical trial led by Margaret Reynolds, MD, MSCI, from WashU Medicine John F. Hardesty, MDDepartment of Ophthalmology & Visual Sciences explored whether vision correction surgery could make a meaningful difference, not just in eyesight, but also in behavior and daily life. The trial included 267 children with ASD or ASD-like behaviors and vision problems […]
The WashU Medicine John F. Hardesty, MD Department of Ophthalmology & Visual Sciences has received a notice of award for a new clinical trial focused on advancing treatment options for patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The study, titled “Efficacy of Dapagliflozin in Geographic Atrophy Secondary to Age-Related Macular Degeneration: […]
Congratulations to WashU Ophthalmology Resident, Matt Elitt, MD, PhD and Case Western Reserve’s Tesar Lab colleagues, on the advancement of ION356 to a phase I human clinical trial. Dr. Elitt’s doctoral research published in Nature demonstrated a novel method to pharmacologically target the pathology of Pelizaeus-Merzbacher disease (PMD), representing the first potential treatment option for patients and […]